Porcine reproductive and respiratory syndrome virus (PRRSV) is a small enveloped RNA virus which has been found to be the causative agent of a new disease in pigs that occurs in North America and Europe (3, 5, 25) . The disease is characterized by severe reproductive failure in sows of any parity and respiratory problems affecting pigs of all ages (10) .
PRRSV has provisionally been classified within the genus Arterivirus, according to its morphological and biochemical characteristics (1, 4, 22) . This new group of viruses includes equine arteritis virus, lactate dehydrogenase-elevating virus, and simian hemorrhagic fever virus (2) . The viral genome is a positive single-stranded polyadenylated RNA molecule approximately 15 kb in length that contains eight open reading frames (ORFs). Two-thirds of the genome is represented by ORF1a and ORF1b, which are predicted to encode for viral RNA polymerase and associated proteases (4, 22) . The transcriptional mechanism of genomic RNA involves the synthesis in PRRSV-infected cells of a 3Ј coterminal nested set of six major subgenomic mRNAs, sharing a common 5Ј end leader sequence (4, 18, 20) . The virion contains three major structural proteins: a predominant nucleocapsid (N) protein of 14 to 15 kDa, an unglycosylated membrane (M) protein of 18 to 19 kDa, and a glycosylated membrane (E) protein of 25 to 26 kDa. These proteins are encoded by ORFs 7, 6 , and 5, respectively (16, 21, 24) .
Although the clinical syndromes associated with PRRSV infection are similar in North America and Europe (10) , antigenic variations have been reported among U.S. and European isolates and among U.S. isolates (13, 24, 26, 29) . Recently, monoclonal antibodies (MAbs) directed against the N proteins of two reference U.S. strains, ATCC VR2332 and SD-1, have been reported to differentiate among North American and European isolates of PRRSV (24) , thus confirming the sequence analysis of their N protein genes (15, 19) . Similar comparative studies among U.S. and Canadian PRRSV isolates revealed close antigenic and genomic relationships (13, 17) . So far, clinical and pathological evidence suggests the existence of nonpathogenic to highly pathogenic PRRSV strains among North American PRRSV strains, but the identification of distinct North American serotypes still remains to be demonstrated (10) .
In the present report we describe the characterization of three MAbs that have been obtained by immunization with a tissue culture-adapted Quebec reference strain of PRRSV; two of the MAbs were found to be directed against the nonglycosylated M protein. These MAbs were used to investigate the serological relationships among field isolates that have been associated with PRRSV infections in Canadian pig farms, two reference European strains, and the U.S. attenuated vaccine strain ATCC VR2332.
inary Science, South Dakota State University. The IIF test was carried out with acetone fixed PRRSV-infected MARC-145 cells and fluorescein-conjugated anti-pig (Sigma) or anti-mouse (Boehringer Mannheim, Laval, Quebec, Canada) immunoglobulin G (IgG) as described previously (13, 27) . The IIF antibody titers were expressed as the reciprocal of the highest serum dilution giving specific cytoplasmic fluorescence.
The IAF-Klop strain was plaque purified twice and yielded titers of 10 5 to 10 6 50% tissue culture infective doses (TCID 50 s) per ml after five successive passages in MARC-145 cells. An homologous hyperimmune serum sample was obtained following three intramuscular injections of the purified virus preparation (200 g of viral proteins) given at 2-week intervals to specific-pathogen-free piglets (14) . In vitro detection of VN antibodies to PRRSV was done by a procedure modified from one described previously (28) . The VN antibody titers were expressed as the reciprocal of the highest dilution of serum that neutralized the cytopathic effect induced in MARC-145 cell monolayers by a constant dose of 100 TCID 50 s of virus. The reference porcine hyperimmune serum had only weak virus-neutralizing activity (VN titers, 32) when it was tested against the homologous virus, but reached titers of 2,560 to 5,120 by the IIF test. Production and characterization of MAbs to PRRSV. MAbs were prepared as described previously (6) , except that P3x63 Ag8.653 myeloma cells were used. Female BALB/c mice were immunized intraperitoneally with concentrated and sucrose gradient-purified virus (50 g of protein) mixed with Freund's complete (first injection) or incomplete adjuvant. After four injections given at 2-week intervals, titers of serum from mice providing the immune cells ranged from 128 to 256 by the IIF test, whereas virus-neutralizing titers were insignificant (titers, Ͻ8). Nonetheless, three hybridoma cell lines secreting MAbs to the IAF-Klop strain of PRRSV (designated IAFK3, IAFK6, and IAFK8), as determined by the IIF test, could be subcloned, serially propagated, and used to produce ascitic fluids.
None of the anti-PRRSV MAbs described above could neutralize the virus propagated in cell cultures, despite IIF titers of 1,600 to 3,200 for MAbs IAFK3 and IAFK6 and titers as high as 51,200 to 102,400 for MAb IAFK8 ( Table 1) . The subisotypes for these MAbs were determined to be IgG1 for IAFK8 and IgG2b for IAFK3 and IAFK6 by a commercial enzyme immunoassay (Boehringer Mannheim).
An immunoblotting assay and a radioimmunoprecipitation assay (RIPA) were used to determine the viral protein specificities of the various anti-PRRSV MAbs produced in ascitic fluids. The immunoblotting experiments were performed with concentrated extracellular virus (14) and Escherichia coli-expressed ORF 5, 6, and 7 gene products (12, 23) . Replicas of viral proteins or recombinant fusion proteins, separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and electrophoretically transferred onto nitrocellulose membranes, were prepared as described previously (12) . After saturation with 5% BLOTTO (skim milk powder in 0.05 M Tris-buffered saline [TBS] solution), nitrocellulose membranes were incubated for 1 h at room temperature in the presence of either a 1:200 dilution of homologous anti-PRRSV porcine serum or a 1:100 dilution of mouse ascitic fluid. After washing in TBS containing 0.05% Tween 20, the membranes were further incubated in the presence of a 1:1,000 dilution of alkaline phosphatase-conjugated anti-porcine or anti-mouse IgG (Sigma). The immune complexes were revealed by using a commercially available alkaline phosphatase conjugate substrate kit (Bio-Rad, Mississauga, Ontario, Canada) containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate in TBS.
RESULTS
Under reducing conditions, the three structural viral proteins of the tissue culture-adapted IAF-Klop strain of PRRSV (proteins N, M, and E) were consistently revealed by using homologous porcine and rabbit hyperimmune sera ( (Fig. 1B , lanes d and e), whereas no reactivity was observed in the case of MAb IAFK8 and the reference antibody SDOW17 directed against the N protein (Fig. 1B, lanes b and c) . Nonspecific binding to a 24-kDa protein species was also occasionally revealed in the case of MAb IAFK6 (Fig. 1B , lane e). Monospecific antisera toward E. coli-expressed ORFs 7, 6, and 5 of the IAF-Klop strain produced in rabbits (Fig. 1B , lanes f, g, and h, respectively) were used as controls and reacted specifically with the N, M, and E viral proteins, respectively.
In agreement with the reactivity profiles observed with purified virus, MAbs IAFK3 and IAFK6 also reacted by immunoblotting with the recombinant fusion protein glutathione-Stransferase (GST)-ORF6 ( Fig. 2B and C, lanes c). However, both MAbs IAF-K8 and SDOW17 failed to react with the recombinant fusion protein maltose binding protein (MBP)-ORF7 or the recombinant N protein alone (data not shown), which was cleaved with factor Xa (23) . None of the MAbs tested showed reactivity toward the unfused GST (26 kDa) ( Fig. 2A to C, lanes a) or MBP (42.7 kDa) (data not shown) protein. The estimated molecular masses of the recombinant proteins were 48.4 kDa for GST-ORF5, 45.1 kDa for GST-ORF6, and 56.7 kDa for MBP-ORF7, in accordance with the molecular masses predicted from their amino acid sequences (16) .
Since the polypeptide specificity of the IAFK8 MAb could not be determined by immunoblotting and to confirm the reactivity patterns of MAbs IAFK3 and IAFK6, RIPAs were conducted with concentrated preparations of radiolabeled virus. Briefly, confluent monolayers of MARC-145 cells were infected with the IAF-Klop strain at a multiplicity of infection S]methionine (specific activity, 1,120 Ci/mmol; Amersham Searle Co., Oakville, Ontario, Canada) per ml. At the end of the labeling period, the extracellular virus was prepared as described previously (14, 16) . The proteins were immunoprecipitated and the immunocomplexes were analyzed by electrophoresis in SDS-12% polyacrylamide gels in the presence of 2-mercaptoethanol as described elsewhere (16). The three major viral structural proteins, proteins N, M, and E, could be consistently immunoprecipitated by the homologous porcine hyperimmune serum (Fig. 3, lane 1) , but they could not be immunoprecipitated from the supernatants of mock-infected cultures (Fig. 3, lane  2) . As first demonstrated by immunoblotting with purified virus, immunoprecipitation of the M protein was obtained with MAbs IAFK3 and IAFK6, which also appeared to coprecipitate the E glycoprotein (Fig. 3, lanes 5 and 6) . As expected, MAb SDOW17 immunoprecipitated the N protein, as was also the case for MAb IAFK8 (Fig. 3, lanes 3 and 4) , suggesting that these antibodies recognized conformationally dependent epitopes.
Cross-reactivities of MAbs toward European and North American field strains of PRRSV. The second purpose of our study was to determine if MAbs to the M protein could detect antigenic differences among North American and European strains of PRRSV and between the attenuated vaccine strain ATCC VR2332 (Ingelvac; Boehringer Ingelheim) and field isolates recovered from pigs in Quebec with recent clinical cases of porcine reproductive and respiratory syndrome. Overall, 2 European strains and 16 North American PRRSV isolates were tested for their reactivities to anti-M protein and anti-N protein MAbs by the IIF test. Among the North American PRRSV isolates, 12 were collected from specimens that were submitted to the Diagnostic Laboratories for Animal Virology, Institut Armand-Frappier (IAF), Laval, Quebec, Canada (14, 15) . Three additional isolates, ONT-TS, ONT-TB, and IAF-94-3296, were from Ontario, two of which were kindly provided by Susy Carman, Provincial Virology Laboratory, Ontario Ministry of Agriculture, Guelph, Ontario, Canada. The two European isolates, the Lelystad virus and the Weybridge strain, were obtained from G. Wensvoort (National Veterinary Laboratory Center, Lelystad, The Netherlands) and S. Edwards (Central Veterinary Laboratory, Weybridge, United Kingdom), respectively. The PRRSV isolates were cultivated directly or following two preliminary passages on primary cultures of porcine alveolar macrophages or MARC-145 cells; however, the Weybridge strain failed to adapt on the continuous cell line. The attenuated vaccine strain ATCC VR2332, originally isolated on CL2621 cells (1), was also further propagated on MARC-145 cells. All PRRSV isolates except two of the isolates from Ontario (isolates ONT-TS and ONT-TB) were subjected to a minimum of three rounds of limiting dilution in MARC-145 cells. Stock viruses were produced by at least five successive passages in MARC-145 cells, and infectivity titers ranged from 10 5.3 to 10 6.5 TCID 50 s/ml. The IIF test was used to titrate each of the six MAbs against all isolates. The results of antigenic comparisons between North American and European isolates of PRRSV with the anti-N protein and anti-M protein MAbs are summarized in Table 2 . Comparable antibody titers were obtained for the IAFK8 and SDOW17 anti-N protein MAbs when they were tested against all of the Canadian isolates, the reference U.S. isolate, and both European strains. As reported previously (13, 24) , both European isolates failed to react to the VO17 and EP147 MAbs; surprisingly, two of the isolates from Ontario (isolates ONT-TS and ONT-TB) also were not recognized by these anti-N protein MAbs. The other Canadian isolates reacted to MAbs VO17 and EP147 with titers similar to that obtained for the attenuated vaccine strain ATCC VR2332. On the other hand, nine of the PRRSV isolates from Quebec and one of the PRRSV isolates from Ontario (isolate IAF 94-3296) reacted positively at approximately the same titers to IAFK3 and IAFK6 MAbs. Interestingly, neither the U.S. reference vaccine strain ATCC VR2332, showing no reactivity to either of the anti-M protein MAbs; the third group of isolates comprised two of the Ontario isolates (isolates ONT-TS and ONT-TB) and were associated with the European isolates since no reactivity was observed with the anti-N protein MAbs VO17 and EP147 or either anti-M MAb.
DISCUSSION
Prior to the present study, MAbs produced against two PRRSV U.S. isolates (ATCC VR2332 and SD-1) and one PRRSV isolate from the United Kingdom (H2; from Humberside United Kingdom) were reported and were used to investigate the antigenic differences among North American and European strains (8, 24) . Immunoprecipitation and Western immunoblotting experiments with purified virus revealed that all of the anti-PRRSV MAbs characterized except MAb WBE2 were directed against either common or distinct epitopes of the 15-kDa nucleocapsid protein; MAb WBE2 was found to be directed against a 45-kDa protein determined to be the product of ORF3 (8, 24) . Most of the anti-N protein MAbs which have been previously characterized appeared to be directed against conformationally dependent epitopes, and consequently, their protein specificities could only be determined by RIPA (24) . In the case of MAbs produced against the H2 strain, the specificities of four anti-N MAbs were further confirmed by RIPA by using in vitro-translated products of the Lelystad virus genome (8) . In the present study, the N protein specificity of the IAFK8 MAb could also be determined by RIPA, since no reactivity to the purified virus was observed by immunoblotting. However, a weak signal was obtained when this MAb was tested by immunoblotting toward E. coli-expressed ORF7 product. For this reason, we also postulated that MAb IAFK8 may be directed against a conformationally dependent epitope of the N protein.
Interestingly, two of the MAbs (MAbs IAFK3 and IAFK6) raised against the Quebec IAF-Klop strain were found to be directed against the 19-kDa protein of PRRSV, and their viral protein specificities could be determined by immunoblotting and RIPA. Recent experiments showed that this protein is the product of the ORF6 gene, the putative unglycosylated matrix or membrane (M) protein (16, 21) . In the present study, the anti-M protein specificities of the IAFK3 and IAFK6 MAbs were further confirmed by showing their restrictive reactivity with the E. coli-expressed ORF6 product. The fact that coprecipitation of the E glycoprotein was obtained following incubation with these two anti-M protein MAbs is in agreement with recent findings which showed that the two major envelope proteins of both equine arteritis virus and lactate dehydrogenase-elevating virus occur in disulfide-linked heterodimers in virions and infected cells (7, 9) .
A number of serological studies have revealed differences among isolates of PRRSV, most markedly, between those from North American and European countries (13, 24, 26) . These antigenic differences between strains from both continents have been particularly emphasized with a panel of three MAbs specific for the N protein of PRRSV (24): MAb SDOW17, which was generated against the PRRSV isolate ATCC VR2332, and MAbs EP147 and VO17, which were generated against PRRSV isolate SD-1. Until recently, all three MAbs were reported to react, as determined by the IIF test, with isolates originating from the United States and Canada (13, 24) , with the exception of a few newly isolated strains from Pennsylvania and North Carolina, which lacked reactivity to (24) . Similarly, none of the four anti-N protein MAbs which were recently raised against the British isolate H2 bound to U.S. isolates, which further indicates a consistent antigenic difference between the N proteins of U.S. and European isolates (8) . These observations correlated with subsequent revelations of significant differences in the ORF7 genes of European and American isolates, whereas lesser differences have been shown among isolates from the United States and Canada (15, (17) (18) (19) .
The results obtained in the present study also indicate that North American isolates are antigenically more diverse than previously demonstrated, especially if the comparison is extended to structural proteins other than the N protein. Serological comparison of Canadian isolates with two reference European strains by using the anti-PRRSV porcine hyperimmune serum raised against the Quebec IAF-Klop strain, as well as MAbs directed to the N and M proteins, confirmed their close antigenic relationships, but it also revealed the occurrence of at least three distinct antigenic subgroups. These subgroups were identified by using MAbs directed to one or two distinct antigenic domains of the N protein (MAbs VO17 and EP147) and MAbs that recognized epitopes located on the M protein. The demonstration that MAbs to the M protein could differentiate between North American and European PRRSV isolates is not surprising since it could have been predicted from comparative analyses of the amino acid sequences of their ORF6 products, which revealed only 78 to 81% homologies (16, 19) . More interestingly, both anti-M protein MAbs raised against the Quebec IAF-Klop isolate could also define antigenic variability among local isolates. These observations do not correlate with previous genomic studies, which did not permit the identification of significant differences among isolates from the United States (19) and between the U.S. VR2385 and the Quebec IAF-Klop isolates (16) . Sequence analysis of the structural genes of the various PRRSV isolates that were serologically compared in the present study are in progress in order to identify the genomic regions encoding putative variable antigenic determinants. Such studies should also demonstrate if epitopes of the M protein that distinguish European and North American isolates are similar to those involved in the antigenic variability observed among North American isolates.
